Since the objective of this Regulation, namely to ensure an appropriate protection period for data for active substance/product-type combinations for which a decision on the approval had not been adopted by 7 June 2018, cannot be sufficiently achieved by the Member States but can rather, by reason of the scale and effects of the action, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty on European Union. In accordance with the principle of proportionality as set out in that Article, this Regulation does not go beyond what is necessary in order to achieve that objective.
Recital 8, Regulation (EU) 2026/1165
In forcesince 20 May 2026